Talaromyces marneffei: Difference between revisions

Revision as of 14:15, 21 February 2025

Species of fungus

Talaromyces marneffei, formerly known as Penicillium marneffei, is a dimorphic fungus endemic to Southeast Asia. It is a significant opportunistic pathogen in immunocompromised individuals, particularly those with HIV/AIDS.

Morphology

Talaromyces marneffei exhibits dimorphism, meaning it can exist in two different forms depending on the temperature. At 25°C, it grows as a mold, producing characteristic greenish colonies with a red pigment that diffuses into the medium. At 37°C, it converts to a yeast-like form, which is the pathogenic form in humans.

Pathogenesis

Talaromyces marneffei infection, known as talaromycosis, occurs primarily in individuals with weakened immune systems. The fungus is inhaled as spores, which then convert to the yeast form in the body, leading to systemic infection. Symptoms include fever, weight loss, and respiratory issues, often resembling tuberculosis or histoplasmosis.

Diagnosis

Diagnosis of Talaromyces marneffei infection is typically made through culture of the organism from clinical specimens such as blood, bone marrow, or skin lesions. Microscopic examination can reveal the characteristic yeast cells with transverse septa.

Treatment

The treatment of choice for talaromycosis is amphotericin B, followed by itraconazole for maintenance therapy. Early diagnosis and treatment are crucial to prevent severe complications and mortality.

Epidemiology

Talaromyces marneffei is endemic to regions of Southeast Asia, including Thailand, Vietnam, and southern China. It is associated with bamboo rat habitats, although the exact ecological niche and mode of transmission to humans remain under investigation.

Prevention

Preventive measures for talaromycosis include avoiding exposure to environments where the fungus is endemic, particularly for individuals with compromised immune systems. Prophylactic antifungal therapy may be considered for high-risk patients.

Related pages

File:James Gathany, CDC, CC-BY icon.svg

Image by James Gathany, CDC

@@ Line 1: / Line 1: @@
-{{Short description|A pathogenic fungus causing infection in humans}}
+{{Short description|Species of fungus}}
+{{Taxobox
+| name = Talaromyces marneffei
+| image = Penicillium_marneffei_colony.jpg
+| image_caption = Colony of ''Talaromyces marneffei''
+| regnum = Fungi
+| divisio = Ascomycota
+| classis = Eurotiomycetes
+| ordo = Eurotiales
+| familia = Trichocomaceae
+| genus = ''Talaromyces''
+| species = '''''T. marneffei'''''
+| binomial = ''Talaromyces marneffei''
+| binomial_authority = (Segretain) Samson, N. Yilmaz & Frisvad
+}}
-'''Talaromyces marneffei''' is a [[dimorphic fungus]] that is a significant [[pathogen]] in [[immunocompromised]] individuals, particularly those with [[HIV/AIDS]]. It is endemic to Southeast Asia and is known to cause a systemic infection known as [[penicilliosis]].
+'''''Talaromyces marneffei''''', formerly known as '''''Penicillium marneffei''''', is a [[dimorphic fungus]] endemic to Southeast Asia. It is a significant [[opportunistic pathogen]] in [[immunocompromised]] individuals, particularly those with [[HIV/AIDS]].
 ==Morphology==
-[[File:Talaromyces marneffei culture.jpg|thumb|right|Talaromyces marneffei culture showing characteristic red pigment]]
+''Talaromyces marneffei'' exhibits [[dimorphism]], meaning it can exist in two different forms depending on the temperature. At 25°C, it grows as a mold, producing characteristic greenish colonies with a red pigment that diffuses into the medium. At 37°C, it converts to a yeast-like form, which is the pathogenic form in humans.
-Talaromyces marneffei exhibits dimorphism, meaning it can exist in two different forms depending on the temperature. At 25°C, it grows as a mold, producing septate hyphae and conidia. At 37°C, it converts to a yeast-like form, which is the pathogenic form in humans. The mold form is characterized by the production of a distinctive red pigment.
-==Epidemiology==
-Talaromyces marneffei is primarily found in Southeast Asia, including countries such as Thailand, Vietnam, and southern China. It is associated with bamboo rats, which are considered a natural reservoir for the fungus. Human infection occurs through inhalation of airborne conidia.
 ==Pathogenesis==
-Once inhaled, the conidia of Talaromyces marneffei transform into the yeast form within the host's body. This form is capable of surviving and replicating within [[macrophages]], leading to a disseminated infection. The infection is particularly severe in individuals with compromised immune systems, such as those with HIV/AIDS.
+''Talaromyces marneffei'' infection, known as [[talaromycosis]], occurs primarily in individuals with weakened immune systems. The fungus is inhaled as spores, which then convert to the yeast form in the body, leading to systemic infection. Symptoms include fever, weight loss, and respiratory issues, often resembling [[tuberculosis]] or [[histoplasmosis]].
-==Clinical Manifestations==
-The clinical presentation of Talaromyces marneffei infection can vary but often includes symptoms such as fever, weight loss, and respiratory symptoms. Skin lesions resembling molluscum contagiosum are also common. In severe cases, the infection can spread to multiple organs, leading to a life-threatening condition.
 ==Diagnosis==
-[[File:Talaromyces marneffei histology.jpg|thumb|left|Histological section showing Talaromyces marneffei yeast cells]]
+Diagnosis of ''Talaromyces marneffei'' infection is typically made through culture of the organism from clinical specimens such as blood, bone marrow, or skin lesions. Microscopic examination can reveal the characteristic yeast cells with transverse septa.
-Diagnosis of Talaromyces marneffei infection is typically made through culture of the organism from clinical specimens such as blood, bone marrow, or skin lesions. Histopathological examination can also reveal the presence of the yeast form within tissue samples. Serological tests and molecular methods such as PCR are also used for diagnosis.
 ==Treatment==
-The treatment of choice for Talaromyces marneffei infection is [[amphotericin B]], followed by itraconazole for maintenance therapy. Early diagnosis and treatment are crucial to prevent severe complications and improve outcomes.
+The treatment of choice for talaromycosis is [[amphotericin B]], followed by [[itraconazole]] for maintenance therapy. Early diagnosis and treatment are crucial to prevent severe complications and mortality.
+==Epidemiology==
+''Talaromyces marneffei'' is endemic to regions of Southeast Asia, including Thailand, Vietnam, and southern China. It is associated with bamboo rat habitats, although the exact ecological niche and mode of transmission to humans remain under investigation.
 ==Prevention==
-Preventive measures include reducing exposure to environments where the fungus is endemic, particularly for immunocompromised individuals. Prophylactic antifungal therapy may be considered for high-risk patients.
+Preventive measures for talaromycosis include avoiding exposure to environments where the fungus is endemic, particularly for individuals with compromised immune systems. Prophylactic antifungal therapy may be considered for high-risk patients.
 ==Related pages==
 * [[Fungal infection]]
+* [[Opportunistic infection]]
 * [[HIV/AIDS]]
-* [[Dimorphic fungi]]
 * [[Amphotericin B]]
+* [[Itraconazole]]
+[[File:James_Gathany,_CDC, CC-BY_icon.svg|thumb|left|Image by James Gathany, CDC]]
-[[Category:Fungal diseases]]
+[[Category:Talaromyces|marneffei]]
 [[Category:Dimorphic fungi]]
-[[Category:Pathogenic fungi]]
+[[Category:Opportunistic pathogens]]
+[[Category:Fungi described in 1956]]